SECreport

Form 4 Arch Therapeutics, Inc. For: Dec 20 Filed by: SULAT JAMES R

Arch Therapeutics, Inc.  (ARTH) 
NASDAQ:AMEX Investor Relations: ir.archtherapeutics.com